AstraZeneca bets $1 billion on revolutionary cancer therapy
The Guardian - 17-Mar-2025AstraZeneca acquires EsoBiotec to revolutionize cell therapy with faster, more accessible treatments
Join the club for FREE to access the whole archive and other member benefits.
Financial reporter for the Guardian covering property, insurance and pharmaceuticals
I have 14 years' journalistic experience, reporting on economics, business and finance for newspapers (The Independent, The Guardian, Daily Express, City am and the Swiss newspaper Cash) and newswires (Bloomberg and Market News International). In my spare time I blog for the Collective Review and xfxthemag on art and film.
Visit website: https://muckrack.com/juliakollewe
Details last updated 27-Dec-2019
AstraZeneca acquires EsoBiotec to revolutionize cell therapy with faster, more accessible treatments
British researchers and startups vie to outpace tech billionaires in the fight against ageing
The more people looking at clever new ways to beat cancer the better